Atlas Trials

Evaluate the Efficacy and Safety of Probiotic 6600 as an Adjuvant Therapy for Colitis

Clinical trial NCT07047339 · RECRUITING

Trial details

NCT number
NCT07047339
Sponsor
Changhai Hospital
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
ColitisIBD (Inflammatory Bowel Disease)Probiotic Intervention
Start date
2025-07-01
Primary completion
2026-07-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.